Horch Raymund E, Beier Justus P, Kneser Ulrich, Arkudas Andreas
Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuernberg, Erlangen, Germany.
J Cell Mol Med. 2014 Jul;18(7):1478-85. doi: 10.1111/jcmm.12296. Epub 2014 May 6.
Tissue Engineering (TE) and Regenerative Medicine (RM) have gained much popularity because of the tremendous prospects for the care of patients with tissue and organ defects. To overcome the common problem of donor-site morbidity of standard autologous bone grafts, we successfully combined tissue engineering techniques for the first time with the arteriovenous loop model to generate vascularized large bone grafts. We present two cases of large bone defects after debridement of an osteomyelitis. One of the defects was localized in the radius and one in the tibia. For osseus reconstruction, arteriovenous loops were created as vascular axis, which were placed in the bony defects. In case 1, the bone generation was achieved using cancellous bone from the iliac crest and fibrin glue and in case 2 using a clinically approved β-tricalciumphosphate/hydroxyapatite (HA), fibrin glue and directly auto-transplanted bone marrow aspirate from the iliac crest. The following post-operative courses were uneventful. The final examinations took place after 36 and 72 months after the initial operations. Computer tomogrphy (CT), membrane resonance imaging (MRI) and doppler ultrasound revealed patent arterio-venous (AV) loops in the bone grafts as well as completely healed bone defects. The patients were pain-free with normal ranges of motion. This is the first study demonstrating successfully axially vascularized in situ tissue engineered bone generation in large bone defects in a clinical scenario using the arteriovenous loop model without creation of a significant donor-site defect utilizing TE and RM techniques in human patients with long-term stability.
组织工程(TE)和再生医学(RM)因其在治疗组织和器官缺损患者方面的巨大前景而备受关注。为了克服标准自体骨移植常见的供体部位并发症问题,我们首次成功地将组织工程技术与动静脉环模型相结合,以生成血管化的大骨移植体。我们展示了两例骨髓炎清创术后的大骨缺损病例。其中一例缺损位于桡骨,另一例位于胫骨。对于骨重建,以动静脉环作为血管轴,将其置于骨缺损处。病例1使用来自髂嵴的松质骨和纤维蛋白胶实现了骨生成,病例2使用临床批准的β - 磷酸三钙/羟基磷灰石(HA)、纤维蛋白胶以及直接自体移植的来自髂嵴的骨髓抽吸物。术后过程顺利。最终检查在初次手术后36个月和72个月进行。计算机断层扫描(CT)、磁共振成像(MRI)和多普勒超声显示骨移植体中的动静脉(AV)环通畅,骨缺损完全愈合。患者无痛,活动范围正常。这是第一项研究,在临床场景中,使用动静脉环模型,在大骨缺损中成功实现轴向血管化原位组织工程骨生成,且未利用TE和RM技术造成明显的供体部位缺损,在人类患者中具有长期稳定性。